Coexisting Macular Hole and Uveal Melanoma: A Case Series and Literature Review
- Author:
Yeji KIM
1
;
So Hyun YU
;
Yong Joon KIM
;
Eun Young CHOI
;
Sung Chul LEE
;
Christopher Seungkyu LEE
Author Information
- Publication Type:Original Article
- From:Korean Journal of Ophthalmology 2025;39(2):170-180
- CountryRepublic of Korea
- Language:English
-
Abstract:
Purpose:To report five cases of macular hole (MH) coexisting with uveal melanoma (UM) and review the literature.
Methods:Seventeen patients (5 new and 12 from previous reports) with coexisting MH and UM were reviewed. The patients were divided into two groups based on whether the MH was diagnosed before or after tumor treatment. The clinical features, pathogenesis, management options, and clinical outcomes were reviewed.
Results:Of 505 patients with UM in our institution, 5 (1.0%) had a concurrent MH in the ipsilateral eye. The 17 patients reviewed had a mean age of 63.9 years at the time of MH diagnosis. Of 16 patients with available data on sex, 11 (64.7%) were female. There were no major differences in the demographic or clinical data of the groups. Of the 15 known tumor locations, 6 (35.3%) were juxtapapillary or macular. In patients who developed MH after UM treatment, the durations from tumor treatment (radiotherapy or transpupillary thermotherapy) to MH diagnosis were 3 to 56 months (median, 8.5 months). MH surgery was performed in nine eyes, and hole closure was achieved in seven eyes with postoperative data. The mean visual acuity showed a tendency of improvement after surgery. No intraocular or extraocular tumor dissemination associated with surgery was observed.
Conclusions:MH is observed in approximately 1% of patients with UM, either before or after tumor treatment. Of patients with coexisting MH and UM, MH surgery appears to be safe and effective in those with stable tumors and visual potential.
